Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor

-THERAPEUTIC COMBINATIONS COMPRISING POLY(ADP-RIBOSE) POLYMERASES INHIBITOR Abstract The invention generally relates to use of 8-fluoro-2-{4-[(methylamino)methyl]pheny)}-1, 5 3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one represented by Formula (1) as a chemosensitizer that enhances the efficacy o...

Full description

Saved in:
Bibliographic Details
Main Authors STEINFELDT, HEIDI MARIE, CURTIN, NICOLA JANE, JONES, CHRISTOPHER, THOMAS, HUW DAVID, DEWJI, MOHAMED RAZA, CALVERT, ALAN HILARY, REICH, STEVEN DAVID, NEWELL, DAVID RICHARD, PLUMMER, ELIZABETH RUTH, BORITZKI, THEODORE JAMES, KAUFMAN, RHONDA, HOSTOMSKY, ZDENEK, KLAMERUS, KAREN J, STRATFORD, IAN J, WILLIAMS, KAYE JANINE
Format Patent
LanguageEnglish
Published 12.01.2012
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract -THERAPEUTIC COMBINATIONS COMPRISING POLY(ADP-RIBOSE) POLYMERASES INHIBITOR Abstract The invention generally relates to use of 8-fluoro-2-{4-[(methylamino)methyl]pheny)}-1, 5 3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one represented by Formula (1) as a chemosensitizer that enhances the efficacy of cytotoxic drugs or radiotherapy. The invention also relates to pharmaceutical combinations of 8-fluoro-2-{4-[(methylamino)methylpheny)}-1, 3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one, or a pharmaceutically acceptable salt thereof and at least one additional therapeutic agent, kits containing such combinations and methods of 10 using such combinations to treat subjects suffering from diseases such as cancer.
AbstractList -THERAPEUTIC COMBINATIONS COMPRISING POLY(ADP-RIBOSE) POLYMERASES INHIBITOR Abstract The invention generally relates to use of 8-fluoro-2-{4-[(methylamino)methyl]pheny)}-1, 5 3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one represented by Formula (1) as a chemosensitizer that enhances the efficacy of cytotoxic drugs or radiotherapy. The invention also relates to pharmaceutical combinations of 8-fluoro-2-{4-[(methylamino)methylpheny)}-1, 3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one, or a pharmaceutically acceptable salt thereof and at least one additional therapeutic agent, kits containing such combinations and methods of 10 using such combinations to treat subjects suffering from diseases such as cancer.
Author DEWJI, MOHAMED RAZA
JONES, CHRISTOPHER
KAUFMAN, RHONDA
THOMAS, HUW DAVID
WILLIAMS, KAYE JANINE
REICH, STEVEN DAVID
CALVERT, ALAN HILARY
STRATFORD, IAN J
STEINFELDT, HEIDI MARIE
NEWELL, DAVID RICHARD
BORITZKI, THEODORE JAMES
HOSTOMSKY, ZDENEK
PLUMMER, ELIZABETH RUTH
KLAMERUS, KAREN J
CURTIN, NICOLA JANE
Author_xml – fullname: STEINFELDT, HEIDI MARIE
– fullname: CURTIN, NICOLA JANE
– fullname: JONES, CHRISTOPHER
– fullname: THOMAS, HUW DAVID
– fullname: DEWJI, MOHAMED RAZA
– fullname: CALVERT, ALAN HILARY
– fullname: REICH, STEVEN DAVID
– fullname: NEWELL, DAVID RICHARD
– fullname: PLUMMER, ELIZABETH RUTH
– fullname: BORITZKI, THEODORE JAMES
– fullname: KAUFMAN, RHONDA
– fullname: HOSTOMSKY, ZDENEK
– fullname: KLAMERUS, KAREN J
– fullname: STRATFORD, IAN J
– fullname: WILLIAMS, KAYE JANINE
BookMark eNrjYmDJy89L5WTwCslILUosSC0tyUxWSM7PTcrMSyzJzM8rBnEKijKLM_PSFQrycyo1HF0CdIsyk_KLUzXBArlAfcWpxQqZeRmZSZkl-UU8DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSTeMdTIwNDQyNTYwtDM0dCYOFUAbcQ4Lw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2011253816A1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2011253816A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:50:47 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2011253816A13
Notes Application Number: AU20110253816
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120112&DB=EPODOC&CC=AU&NR=2011253816A1
ParticipantIDs epo_espacenet_AU2011253816A1
PublicationCentury 2000
PublicationDate 20120112
PublicationDateYYYYMMDD 2012-01-12
PublicationDate_xml – month: 01
  year: 2012
  text: 20120112
  day: 12
PublicationDecade 2010
PublicationYear 2012
RelatedCompanies PFIZER INC
CANCER RESEARCH TECHNOLOGY LTD
RelatedCompanies_xml – name: PFIZER INC
– name: CANCER RESEARCH TECHNOLOGY LTD
Score 2.8398464
Snippet -THERAPEUTIC COMBINATIONS COMPRISING POLY(ADP-RIBOSE) POLYMERASES INHIBITOR Abstract The invention generally relates to use of...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Therapeutic combinations comprising poly(ADP-ribose) polymerases inhibitor
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120112&DB=EPODOC&locale=&CC=AU&NR=2011253816A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVfFRJaAEPQTJa9NLkTQPSqFtkFR6K252g4GShCQi_ntn19T21FuyC8tm4JvJfLvzDcAjNSnhxEk1oRyiWZykGk0sopkILE6pMaCyad90RsYLa7K0lx1Yb2phpE7otxRHREQliPdG-utyS2L58m5l_UIzHCpew3joq212rItwZqj-aBhEc3_uqZ6HmaQ6e5NUoGGLUzIXc6UD8SMtlPaD95GoSyl3g0p4CocRrpc3Z9DheQ-OvU3vtR4cTdsjb3xs0VefwyTeFkspuF1Mav_4NvEi9AwxDCllsf55cv1IqzJa1PxZDgjmqea1kuWfGUUMVxfwEAaxN9ZwU6t_G6zcxe4XmJfQzYucX4EySJiuJ8w2RBtpw2Ho3RgjOkkdixH2oV9Df99KN_unb-FEWFVwDrrRh25TffE7jMINvZfG-wVJWou5
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8NAEB1KFetNq-JH1YAS9BAkX5teirRJSqz9CJJKb8XNbjFQktBExH_v7JrannpLdmHZDLwd3tvMG4B7alLCibPQhHOIZnGy0GhsEc1EYHFKjTaVTftGYxJMrcHMntVgua6FkT6h39IcEREVI95LeV7nGxHLk_9WFk80waHsuR91PLVix7pIZ4bq9Tp-OPEmruq6yCTV8ZuUAg1b3JJ1kSvtOUgKhdO-_94TdSn5dlLpH8F-iOul5THUeNqEhrvuvdaEg1F15Y2PFfqKExhEm2IpBbeLpPZPbxMvws8Q05CSZ8ufh64XaquEZgV_lANCeSp4oSTpZ0IRw6tTuOv7kRtouKn5fwzm3en2F5hnUE-zlJ-D0o6ZrsfMNkQbacNheLoxRnSycCxG2Id-Aa1dK13unr6FRhCNhvPhy_j1Cg5FhIX-oBstqJerL36NGbmkNzKQv_jgjqQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Therapeutic+combinations+comprising+poly%28ADP-ribose%29+polymerases+inhibitor&rft.inventor=STEINFELDT%2C+HEIDI+MARIE&rft.inventor=CURTIN%2C+NICOLA+JANE&rft.inventor=JONES%2C+CHRISTOPHER&rft.inventor=THOMAS%2C+HUW+DAVID&rft.inventor=DEWJI%2C+MOHAMED+RAZA&rft.inventor=CALVERT%2C+ALAN+HILARY&rft.inventor=REICH%2C+STEVEN+DAVID&rft.inventor=NEWELL%2C+DAVID+RICHARD&rft.inventor=PLUMMER%2C+ELIZABETH+RUTH&rft.inventor=BORITZKI%2C+THEODORE+JAMES&rft.inventor=KAUFMAN%2C+RHONDA&rft.inventor=HOSTOMSKY%2C+ZDENEK&rft.inventor=KLAMERUS%2C+KAREN+J&rft.inventor=STRATFORD%2C+IAN+J&rft.inventor=WILLIAMS%2C+KAYE+JANINE&rft.date=2012-01-12&rft.externalDBID=A1&rft.externalDocID=AU2011253816A1